4//SEC Filing
JACOB LEONARD S 4
Accession 0001016169-21-000005
CIK 0001016169other
Filed
Aug 30, 8:00 PM ET
Accepted
Aug 31, 6:26 PM ET
Size
8.7 KB
Accession
0001016169-21-000005
Insider Transaction Report
Form 4
JACOB LEONARD S
Director
Transactions
- Tax Payment
Common Stock
2021-08-27$4.00/sh−13,820$55,280→ 295,575 total - Award
Common Stock
2021-08-27$2.24/sh+24,679$55,281→ 309,395 total - Exercise/Conversion
Stock Option (right to buy)
2021-08-27+24,679→ 0 totalExercise: $2.24From: 2021-08-27Exp: 2021-09-08→ Common Stock (24,679 underlying)
Footnotes (2)
- [F1]Represents the number of shares withheld by the company to cover the exercise price for the underlying stock option exercise. No shares were actually sold.
- [F2]The options vested and became exercisable one year from the grant date of September 9, 2011. The stock options were due to expire on September 8, 2021.
Documents
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeother
IncorporatedNY
Related Parties
1- filerCIK 0001049713
Filing Metadata
- Form type
- 4
- Filed
- Aug 30, 8:00 PM ET
- Accepted
- Aug 31, 6:26 PM ET
- Size
- 8.7 KB